Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$118.38 - $210.04 $174,492 - $309,598
1,474 New
1,474 $264,000
Q1 2022

May 03, 2022

SELL
$126.46 - $235.05 $126 - $235
-1 Reduced 0.07%
1,474 $254,000
Q4 2021

Feb 11, 2022

BUY
$225.82 - $368.51 $86,037 - $140,402
381 Added 34.83%
1,475 $375,000
Q3 2021

Nov 10, 2021

SELL
$221.9 - $484.47 $24,409 - $53,291
-110 Reduced 9.14%
1,094 $421,000
Q2 2021

Aug 12, 2021

BUY
$129.91 - $234.98 $156,411 - $282,915
1,204 New
1,204 $282,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Hoyle Cohen, LLC Portfolio

Follow Hoyle Cohen, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hoyle Cohen, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hoyle Cohen, LLC with notifications on news.